Published in J Cell Biol on November 01, 1985
Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol (1989) 6.55
92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol (1991) 2.79
The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol (1990) 2.36
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin, and synthetic peptides. J Cell Biol (1986) 1.62
Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J Cell Biol (1992) 1.39
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest (1987) 1.28
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci U S A (1987) 1.13
Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis (1996) 1.03
Interaction between pathogenic amebas and fibronectin: substrate degradation and changes in cytoskeleton organization. J Cell Biol (1988) 0.98
Collagen fibril growth during chicken tendon development: matrix metalloproteinase-2 and its activation. Cell Tissue Res (2009) 0.94
Human plasma fibronectin as a substrate for human urokinase. Biochem J (1989) 0.94
Cancer cachexia: its correlations and causes. Proc Natl Acad Sci U S A (2003) 0.93
Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J Cell Biol (1988) 0.91
Transformation-associated cytokine 9E3/CEF4 is chemotactic for chicken peripheral blood mononuclear cells. J Virol (1993) 0.86
Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation. Biochem J (1994) 0.83
Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes. Proc Natl Acad Sci U S A (1991) 0.83
Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases. Mol Cell Biol (1993) 0.80
Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1. Proc Natl Acad Sci U S A (1997) 0.77
An instructive role for the interstitial matrix in tissue patterning: tissue segregation and intercellular invasion. J Cell Biol (1990) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
How does the extracellular matrix direct gene expression? J Theor Biol (1982) 6.38
Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (1980) 5.84
Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol (1981) 5.60
Cell surface proteins and malignant transformation. Biochim Biophys Acta (1976) 4.33
Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts. Proc Natl Acad Sci U S A (1976) 4.32
Restoration of normal morphology, adhesion and cytoskeleton in transformed cells by addition of a transformation-sensitive surface protein. Cell (1977) 3.36
Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth. Cancer Res (1978) 2.86
Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc Natl Acad Sci U S A (1980) 2.71
Selective chemical modification of proteins. Physiol Rev (1970) 2.50
Studies on intercellular LETS glycoprotein matrices. Cell (1978) 2.44
The control of cellular morphology in embryonic cells infected with rous sarcoma virus in vitro. Virology (1960) 2.39
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci U S A (1979) 2.25
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Immunological characterization of a major transformation-sensitive fibroblast cell surface glycoprotein. Localization, redistribution, and role in cell shape. J Cell Biol (1978) 2.05
Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J Exp Med (1980) 2.00
Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic. Cell (1980) 1.94
Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes. J Cell Biol (1980) 1.84
The preparation of human fibrinogen free of plasminogen. Biochim Biophys Acta (1962) 1.84
Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites. J Cell Biol (1984) 1.71
Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J Cell Biol (1976) 1.69
Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator. Cell (1979) 1.69
Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. Proc Natl Acad Sci U S A (1981) 1.69
Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (1983) 1.63
Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res (1980) 1.59
Substrate-attached glycoproteins mediating adhesion of normal and virus-transformed mouse fibroblasts. J Cell Biol (1974) 1.59
Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. J Biol Chem (1982) 1.48
Degradation of basement membrane by murine tumor cells. J Natl Cancer Inst (1977) 1.45
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem (1974) 1.43
Substrate-attached glycoproteins from normal and virus-transformed cells. Biochemistry (1974) 1.23
Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells. Int J Cancer (1980) 1.20
Growth factors adherent to cell substrate are mitogenically active in situ. Nature (1982) 1.17
The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein. Biochim Biophys Acta (1982) 1.09
E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Acta Biol Med Ger (1981) 1.09
Tumor cell attachment to the vascular endothelium and subsequent degradation of the subendothelial extracellular matrix. Exp Cell Res (1982) 1.08
Degradation of extracellular matrix by mouse trophoblast outgrowths: a model for implantation. J Cell Biol (1983) 1.08
Effects of acidified fetal bovine serum on the fibrinolytic activity and growth of cells in culture. J Cell Physiol (1978) 1.06
Detection, identification, and partial characterization of serine proteases and esterases in biological systems. Anal Biochem (1982) 1.01
Degradation of the subendothelial matrix by tumor cells. Cancer Res (1983) 0.98
Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. Cancer Res (1978) 0.98
Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate. Biochemistry (1980) 0.93
Behavior of cells seeded in isolated fibronectin matrices. J Cell Biol (1983) 0.91
Inhibition of plasminogen activator release from transformed chicken fibroblasts by a protease inhibitor. Cell (1981) 0.87
Plasminogen activator and the membrane of transformed cells. Prog Clin Biol Res (1980) 0.86
In vitro degradation of radiolabelled, intact basement membrane mediated by cellular plasminogen activator. Carcinogenesis (1982) 0.84
Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts. Proc Natl Acad Sci U S A (1983) 0.82
Immunofluorescent histological studies of the role of fibronectin in the expression of the associative preferences of embryonic tissues. J Cell Sci (1981) 0.81
Effects of cocultivation with transformed cells on surface proteins of normal cells. Biochim Biophys Acta (1978) 0.80
Interaction between bedding and sleeping position in the sudden infant death syndrome: a population based case-control study. BMJ (1990) 7.42
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell (1996) 6.52
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (1994) 4.78
Consultation skills of young doctors: I--Benefits of feedback training in interviewing as students persist. Br Med J (Clin Res Ed) (1986) 4.62
Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem (1995) 3.52
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem (1999) 3.06
"Clusters" of anophthalmia in Britain. BMJ (1993) 3.04
Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet (1999) 2.97
Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem (2001) 2.56
Food Poisoning Due to Toxic Substances Formed by Strains of the Cloacae-Aerogenes Group. Am J Public Health Nations Health (1932) 2.34
Streptococcal infection, Tourette syndrome, and OCD: is there a connection? Neurology (2009) 2.33
The polarized distribution of an apical cell surface glycoprotein is maintained by interactions with the cytoskeleton of Madin-Darby canine kidney cells. J Cell Biol (1988) 2.29
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev (2001) 2.08
NOTES ON THE CULTIVATION OF TREPONEMA PALLIDUM. J Exp Med (1915) 2.07
Distribution of (Na+-K+)-stimulated ATPase activity in rat intestinal mucosa. Biochim Biophys Acta (1969) 1.88
Approval of Laboratories for Surgical Pathology in New York State. Am J Public Health Nations Health (1934) 1.87
THE USE OF GLYCEROL AS A PRESERVATIVE FOR MILK SPECIMENS TO BE EXAMINED FOR HEMOLYTIC STREPTOCOCCI. Am J Public Health Nations Health (1933) 1.83
Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J Cell Biol (1976) 1.69
Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator. Cell (1979) 1.69
Postoperative pain control after lumbar spine fusion. Patient-controlled analgesia versus continuous epidural analgesia. Spine (Phila Pa 1976) (1997) 1.65
Changes in tidal volume, frequency, and ventilation induced by their measurement. J Appl Physiol (1972) 1.64
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62
The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen (2005) 1.61
SIDS: risk reduction measures. Early Hum Dev (1994) 1.55
The arterial-alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations. Am Rev Respir Dis (1974) 1.55
Matrix metalloproteinases and processing of pro-TNF-alpha. J Leukoc Biol (1995) 1.54
In vivo gene electroinjection and expression in rat liver. FEBS Lett (1996) 1.53
Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood (2001) 1.50
Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem (1974) 1.50
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Vascular muscle cell depolarization and activation in renal arteries on elevation of transmural pressure. Am J Physiol (1987) 1.48
Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res (1999) 1.44
Rapid aneuploidy screening with fluorescence in-situ hybridisation: is it a sufficiently robust stand-alone test for prenatal diagnosis? Hong Kong Med J (2010) 1.43
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem (1974) 1.43
Teaching skills in communication to medical students--a critical review of the methodology. Med Educ (1981) 1.42
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther (2003) 1.41
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol (2010) 1.41
False-low carbon monoxide diffusing capacity measurement after general anesthesia. Chest (1996) 1.40
Microalbuminuria in diabetes. Med J Aust (1994) 1.38
Consultation skills of young doctors: II--Most young doctors are bad at giving information. Br Med J (Clin Res Ed) (1986) 1.37
Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem (1994) 1.36
An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts. Cell (1986) 1.35
Regulation of epithelial cell surface polarity reversal by beta 1 integrins. J Cell Sci (1994) 1.34
PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest (2000) 1.32
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev (1990) 1.27
Alpha2-macroglobulin: an evolutionarily conserved arm of the innate immune system. Dev Comp Immunol (1999) 1.27
Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma (1993) 1.27
Characterization of proinsulin- and proglucagon-converting activities in isolated islet secretory granules. J Cell Biol (1981) 1.26
Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles. Proc Natl Acad Sci U S A (1978) 1.24
Integrin regulation of cell-cell adhesion during epithelial tubule formation. J Cell Sci (2001) 1.23
Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. Cancer Res (1982) 1.22
Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs (2000) 1.19
Characterization of the conversion of a somatostatin precursor to somatostatin by islet secretory granules. Diabetes (1980) 1.18
Chemical synthesis, cloning and expression in mammalian cells of a gene coding for human tissue-type plasminogen activator. Gene (1988) 1.16
Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol (1988) 1.14
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther (2000) 1.14
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci U S A (1987) 1.13
Fibronectin enhancement of directed migration of B16 melanoma cells. Cancer Res (1984) 1.12
Agglutination in the Diagnosis of Enteric Disease. Am J Public Health Nations Health (1933) 1.12
Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. BJOG (2005) 1.11
Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect (2001) 1.10
Carcinoma of the pancreas causing ureteral obstruction. J Urol (1973) 1.10
Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J Cell Sci (1994) 1.09
Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells. Oncogene (2011) 1.08
Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res (1990) 1.07
Virus-induced modification of cellular membranes related to viral structure. Annu Rev Microbiol (1974) 1.06
Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann N Y Acad Sci (1999) 1.06
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther (2000) 1.06
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res (1979) 1.05
Isolation and characterization of ribonucleoprotein substructures from Rous sarcoma virus. Virology (1972) 1.05
Asynchronous breathing movements in patients with chronic obstructive pulmonary disease. Chest (1975) 1.03
Effect of ventilation on oxygen transfer during early exercise. J Appl Physiol (1966) 1.02
Evidence that B. Alkalescens (Andrewes) May Be a Variant of B. Typhosus Preliminary Report. Am J Public Health Nations Health (1934) 1.02
Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther (2000) 1.02
Lipid studies of Rous sarcoma virus and host cell membranes. Virology (1972) 1.02
In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. Melanoma Res (2000) 1.02
Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol (1997) 1.01
Detection, identification, and partial characterization of serine proteases and esterases in biological systems. Anal Biochem (1982) 1.01
Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill (2008) 0.99
Detection and quantitation of cell-cell electrofusion products by flow cytometry. Anal Biochem (1994) 0.98
Pharmacologic identification, activation and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter. J Pharmacol Exp Ther (1984) 0.98
The role of panendoscopy in the management of mucosal head and neck malignancy-a prospective evaluation. Head Neck (2000) 0.98
Properties of a high specific activity, (Na+-K+)-stimulated ATPase from rat intestinal mucosa. Biochim Biophys Acta (1969) 0.98
Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. Cancer Res (1978) 0.98
Effect of aging on the hepatobiliary transport of dimeric immunoglobulin A in the male Fischer rat. Gastroenterology (1985) 0.97
Relationship of rib cage and abdomen motion to diaphragm function during quiet breathing. Chest (1981) 0.96
D-Dimer in the diagnosis of deep vein thrombosis following total hip and knee replacement: a prospective study. Ann R Coll Surg Engl (2008) 0.94
Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis. Epidemiol Infect (1993) 0.94
Implication of active oxygen species as second messengers of asbestos toxicity. Drug Chem Toxicol (1987) 0.94
Stabilizing electrode-host interfaces: a tissue engineering approach. J Rehabil Res Dev (2001) 0.94
Influence of proprioceptor activity in the ventilatory response to exercise. J Appl Physiol (1966) 0.94
Human plasma fibronectin as a substrate for human urokinase. Biochem J (1989) 0.94